90 related articles for article (PubMed ID: 1234497)
1. An investigation into the cardiac and pulmonary beta-adrenoceptor blocking activity of ICI 66,082 in man.
Marlin GE; Kumana CR; Kaye CM; Smith DM; Turner P
Br J Clin Pharmacol; 1975 Apr; 2(2):151-7. PubMed ID: 1234497
[TBL] [Abstract][Full Text] [Related]
2. The effects of ICI 118,587 and atenolol on the responses to exercise and on breathlessness in healthy subjects.
O'Neill PA; Morton PB; Sharman P; Marlow HF; Stark RD
Br J Clin Pharmacol; 1984 Jan; 17(1):37-41. PubMed ID: 6229263
[TBL] [Abstract][Full Text] [Related]
3. Immediate haemodynamic effects of a novel partial agonist, beta 1-adrenoceptor blocking drug ICI 141,292 after intravenous administration to healthy young volunteers and patients with ischaemic heart disease.
Bonde J; Svendsen TL; Lyngborg K; Mehlsen J; Trap-Jensen J
Br J Clin Pharmacol; 1987 Jan; 23(1):35-40. PubMed ID: 2880603
[TBL] [Abstract][Full Text] [Related]
4. The assessment of the beta-adrenoceptor blocking activity and cardioselectivity of Koe 3290 in normal subjects.
Pringle TH; McNeill AJ; Riddell JG; Shanks RG
Br J Clin Pharmacol; 1987 Nov; 24(5):581-9. PubMed ID: 2893635
[TBL] [Abstract][Full Text] [Related]
5. Assessment of the relative safety of the beta-blockers ICI 141,292 and atenolol in patients with bronchial asthma.
Groth S; Tønnesen P; Asted M; Dirksen H; Sørensen PG
Eur J Clin Pharmacol; 1986; 30(6):653-8. PubMed ID: 3533563
[TBL] [Abstract][Full Text] [Related]
6. Human pharmacokinetic and pharmacodynamic studies on the atenolo (ICI 66,082), a new cardioselective beta-adrenoceptor blocking drug.
Conway FJ; Fitzgerald JD; McAinsh J; Rowlands DJ; Simpson WT
Br J Clin Pharmacol; 1976 Apr; 3(2):267-72. PubMed ID: 973955
[TBL] [Abstract][Full Text] [Related]
7. An investigation of "absolute plasma level effect relationships" and "absolute cardioselectivity" with respect to beta-adrenoceptor blockade.
Kumana CR; Kaye CM; Leighton M; Marlin GE
Eur J Clin Pharmacol; 1977 Aug; 12(1):7-13. PubMed ID: 332505
[TBL] [Abstract][Full Text] [Related]
8. Beta-adrenoceptors and the regulation of blood pressure and plasma renin during exercise.
Hespel P; Lijnen P; Vanhees L; Fagard R; Amery A
J Appl Physiol (1985); 1986 Jan; 60(1):108-13. PubMed ID: 3003020
[TBL] [Abstract][Full Text] [Related]
9. Cardiac and pulmonary effects of acebutolol.
Kumana CR; Kaye CM; Leighton M; Turner P; Hamer J
Lancet; 1975 Jul; 2(7925):89-93. PubMed ID: 49736
[TBL] [Abstract][Full Text] [Related]
10. Haemodynamic long-term effects of a new beta-adrenoceptor blocking drug, atenolol (ICI 66082), in essential hypertension.
Lund-Johansen P
Br J Clin Pharmacol; 1976 Jun; 3(3):445-51. PubMed ID: 973971
[TBL] [Abstract][Full Text] [Related]
11. Effect of atenolol on ventilatory and cardiac function in asthma.
Vilsvik JS; Schaanning J
Br Med J; 1976 Aug; 2(6033):453-5. PubMed ID: 8188
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of the natriuretic and beta-adrenoceptor-blocking effects of tienoxolol in normal volunteers.
Berdeaux A; Loueslati E; Gerard JL; Pussard E; Giudicelli JF
Fundam Clin Pharmacol; 1988; 2(5):441-54. PubMed ID: 2906898
[TBL] [Abstract][Full Text] [Related]
13. Pamatolol: phase I evaluation of the pharmacodynamics of a cardioselective beta adrenoceptor blocking drug.
Carruthers SG; Hosler JP; Pentikainen P; Azarnoff DL
Clin Pharmacol Ther; 1978 Aug; 24(2):168-74. PubMed ID: 28193
[TBL] [Abstract][Full Text] [Related]
14. Comparative beta-adrenoceptor blocking effects and pharmacokinetics of penbutolol and propranolol in man.
Giudicelli JF; Richer C; Chauvin M; Idrissi N; Berdeaux A
Br J Clin Pharmacol; 1977 Apr; 4(2):135-40. PubMed ID: 16632
[TBL] [Abstract][Full Text] [Related]
15. Clinical pharmacologic observations on atenolol, a beta-adrenoceptor blocker.
Brown HC; Carruthers SG; Johnston GD; Kelly JG; McAinsh J; McDevitt DG; Shanks RG
Clin Pharmacol Ther; 1976 Nov; 20(5):524-34. PubMed ID: 10125
[TBL] [Abstract][Full Text] [Related]
16. Differentiation of exercise-induced metabolic responses during selective beta 1- and beta 2-antagonism.
Hespel P; Lijnen P; Vanhees L; Fagard R; Fiocchi R; Moerman E; Amery A
Med Sci Sports Exerc; 1986 Apr; 18(2):186-91. PubMed ID: 3010028
[TBL] [Abstract][Full Text] [Related]
17. The demonstration of atenolol as a beta-adrenoceptor blocking drug in man.
Harry JD
Postgrad Med J; 1977; 53 Suppl 3():65-9. PubMed ID: 928268
[No Abstract] [Full Text] [Related]
18. Role of the Frank-Starling mechanism during maximal semisupine exercise after oral atenolol.
Andersen K; Vik-Mo H
Br Heart J; 1982 Aug; 48(2):149-55. PubMed ID: 7093084
[TBL] [Abstract][Full Text] [Related]
19. Influence of intrinsic sympathomimetic activity and cardioselectivity on beta adrenoceptor blockade.
McDevitt DG; Brown HC; Carruthers SG; Shanks RG
Clin Pharmacol Ther; 1977 May; 21(5):556-66. PubMed ID: 15753
[TBL] [Abstract][Full Text] [Related]
20. Differential haemodynamic effects induced by beta 1-(bisoprolol) or beta 2-(ICI 118,551) adrenoceptor blockade in man.
Daul A; Johnston T; Reher M; Krüger M; Brodde OE
J Hypertens Suppl; 1986 Dec; 4(6):S99-102. PubMed ID: 2886573
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
